Screening for bowel cancer must include general population, not just those at risk

July 03, 2001

Prevalence and family history of colorectal cancer: implications for family screening 2001; 8: 69-72

If screening for bowel cancer is to get the go-ahead, it must include everyone, not just those with a family history, who are known to be at increased risk, reports research in the Journal of Medical Screening.

The UK government is known to be considering setting up a nationwide screening programme for bowel cancer, and pilot studies are already under way. But whom and exactly how to screen have not yet been decided.

A population study of over 30,000 people in Norfolk showed that just under 7 per cent reported a family history of the disease in at least one parent or sibling. Levels of bowel cancer among those with a family history ran to 1 per cent and 0.5 per cent in people with no known family history.

The findings showed that people who had a history of the disease in their family were at greater risk, with 15 per cent of 151 people with the disease falling into this category. Occurrence of the cancer in a close relative more than doubled the risk of developing it. And those with a relative under 45 diagnosed with bowel cancer, or with two relatives with the disease, had up to five times the risk of getting this type of cancer themselves.

But the numbers of cases among people with no family history were far higher, particularly in older age groups and among men. Indeed, the authors comment that around 85 per cent of bowel cancers develop in people who do not have a family history of the disease. Currently recognised genetic factors may account for only five per cent of all bowel cancers detected, they say. "Based on the prevalence estimates reported here," conclude the authors, "screening strategies targeted solely at people with a family history will have limited impact on reducing mortality from colorectal cancer at the population level."

Dr Majinder Sandhu, Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge.

Tel: 44-1223-740-168

BMJ Specialty Journals

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to